NDC 72603-103
Doxorubicin Hydrochloride 2 mg per 1 mL injectable, liposomal
On the label: Northstar Rx LLC..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Halol, India | Makes it and tests it | Serious problems, FDA actionJun 13, 2025 · 12 inspections, 5 with FDA action |
Recalls
- May 12, 2026 · Class I · Sun Pharmaceutical Industries Inc
Presence of Particulate matter: Particulate matter identified as glass.
Lots: Lot HAG2581B, expires: 05/31/2027
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Doxorubicin: every company that makes it
- Form
- injectable, liposomal, intravenous
- Strength
- 2 mg per 1 mL
- Approval
- ANDA ANDA203263
- On the market since
- May 29, 2019
- Package NDCs
72603-103-01- Official label
- DailyMed (National Library of Medicine), updated Apr 10, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?